Q3 2017 13F Holders as of 30 Sep 2017
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
4,992,318
-
Total 13F shares
-
15,693,839
-
Share change
-
+497,432
-
Total reported value
-
$271,344,000
-
Price per share
-
$17.29
-
Number of holders
-
40
-
Value change
-
+$10,576,212
-
Number of buys
-
29
-
Number of sells
-
18
Institutional Holders of Mersana Therapeutics, Inc. - Common Stock, par value $0.0001 per share (MRSN) as of Q3 2017
As of 30 Sep 2017 Mersana Therapeutics, Inc. - Common Stock, par value $0.0001 per share (MRSN) had 40 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 15,693,839 shares of stock of the company.
Largest 10 holders included NEA Management Company, LLC, WELLINGTON MANAGEMENT GROUP LLP, FMR LLC, Rock Springs Capital Management LP, ArrowMark Colorado Holdings LLC, JPMORGAN CHASE & CO, Cormorant Asset Management, LLC, BlackRock Inc., VANGUARD GROUP INC, and Allianz Asset Management GmbH.
This table shows 40 institutional shareholders of the security as of 30 Sep 2017.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.